GlassScriptPhysician profile
Peter Donovan Taylor
NPI 1053373290
$39,914.62
in general payments reported to CMS, 2019-2025
34 companies · $1,599 in 2025
The $1,599 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $5,195 · 2021: $6,329 · 2022: $2,287 · 2023: $5,303 · 2024: $2,280 · 2025: $1,599.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,324 · Consulting Fee: $3,600 · Travel and Lodging: $204 · Gift: $53.66.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,324.25 |
| Consulting Fee | $3,600.00 |
| Travel and Lodging | $203.99 |
| Gift | $53.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $32,035.61 | 2019-2025 | Accent, Gallant, Allure |
| Kestra Medical Technology Services, INC. | $2,418.01 | 2023-2025 | Assure Wcd |
| Medtronic, INC. | $660.36 | 2021-2025 | Linq II |
| Boston Scientific Corporation | $558.93 | 2019-2024 | Lux-Dx Insertable Cardiac Monitor, Emblem Mri S-Icd |
| Novartis Pharmaceuticals Corporation | $535.28 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $367.21 | 2022-2025 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals LP | $315.86 | 2020-2025 | Wainua, Farxiga |
| Shockwave Medical, INC | $313.50 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cvrx, INC. | $233.57 | 2022-2025 | Barostim Neo System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $230.55 | 2019-2023 | Lifevest |
| Medical Device Business Services, INC. | $203.99 | 2023 | Carto 3 |
| Impulse Dynamics (USA) INC. | $175.40 | 2022-2023 | Optimizer |
| Pfizer INC. | $169.03 | 2019-2025 | |
| Biotronik INC. | $161.28 | 2022-2024 | Amvia Edge |
| Alnylam Pharmaceuticals INC. | $160.06 | 2019 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bridgebio Pharma, INC. | $159.76 | 2025 | Attruby |
| Medtronic Vascular, INC. | $155.42 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $153.77 | 2021-2024 | Xarelto |
| Abiomed | $150.60 | 2024 | Impella |
| Elutia, INC. | $140.58 | 2021-2022 | |
| Akcea Therapeutics, INC. | $125.86 | 2019 | |
| Philips North America LLC | $121.95 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $55.57 | 2024 | |
| Kiniksa Pharmaceuticals International, Plc | $55.26 | 2024 | Arcalyst |
| Amgen INC. | $52.54 | 2019-2023 | Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $43.84 | 2025 | |
| Edwards Lifesciences Corporation | $34.92 | 2023 | Sapien 3 Ultra Resilia |
| Atricure, INC. | $25.57 | 2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Lexicon Pharmaceuticals, INC. | $20.04 | 2023 | Inpefa |
| Baxter Healthcare | $19.40 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Esperion Therapeutics, INC. | $17.48 | 2024 | Nexletol |
| Scpharmaceuticals INC. | $15.78 | 2024 | |
| Lilly USA, LLC | $14.30 | 2024 | Zepbound, Mounjaro |
| Sanofi-Aventis U.S. LLC | $13.34 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.